Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colestilan versus calcium-based phosphate binders in pediatric dialysis patients with hyperphosphatemia
2012-002581-12Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of colestilan in hyperphosphatemia (4 arms), sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Mean absolute change in serum phosphorus. Started Oct 2012; status: completed.
02
Drugs
colestilan
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on 2012-002581-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002581-12.